Olinger Margaret
- SEC CIK
- 0001898725
No open-market purchases or sales filed in the past year.
Current role at each company
- AMLX Amylyx Pharmaceuticals, Inc.Chief Commercial Officeras of Dec 29, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Olinger Margaret as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 10, 2023 (view filing) | Jan 6 | 4 days | Olinger MargaretChief Commercial Officer | SSale | +2.40K | $36.30 | +$87.2K | +1.1%214.4K after | 2 lots |
| Jan 10, 2022 (view filing) | Jan 6 | 4 days | Olinger MargaretChief Commercial Officer | PPurchase | +6.84K | $19.00 | +$130.0K | +3.3%216.8K after |